Mahtani, Reshma http://orcid.org/0000-0002-7711-8627
Crawford, Jeffrey
Flannery, Sinéad M.
Lawrence, Tatiana
Schenfeld, Jennifer
Gawade, Prasad L.
Funding for this research was provided by:
Amgen
Article History
Received: 11 August 2020
Accepted: 26 April 2021
First Online: 27 May 2021
Declarations
:
: Not applicable.
: Not applicable.
: TL, JS, and PLG are employees of and hold stock in Amgen, Inc.; SMF is an employee of Oxford PharmaGenesis and Oxford PharmaGenesis has received research funding from Amgen, Inc. RM has received fees as a consultant/advisor for Agendia, Amgen, AstraZeneca, Biotheranostics, Daiichi, Esai, Immunomedics, Lilly, Novartis, Pfizer, Puma, Seattle Genetics and contracted research for Genentech; JC has received grants/research support from AstraZeneca, Genentech and Helsinn, consultant fees from Amgen, AstraZeneca, Coherus Biosciences, Enzychem Lifesciences, G1 Therapeutics, GlaxoSmithKline, Merck, Pfizer and Spectrum, and is a DSMB Member for Beyond Spring, G1 Therapeutics, Merrimack, Mylan and Roche.